Esperanza Merino to Adult
This is a "connection" page, showing publications Esperanza Merino has written about Adult.
Connection Strength
0.046
-
Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study. J Autoimmun. 2020 11; 114:102523.
Score: 0.015
-
Plasma ACE2 species are differentially altered in COVID-19 patients. FASEB J. 2021 08; 35(8):e21745.
Score: 0.004
-
Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series. Int J Clin Pract. 2021 Oct; 75(10):e14599.
Score: 0.004
-
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021 03; 82(3):378-383.
Score: 0.004
-
Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients. Int J Infect Dis. 2020 Nov; 100:449-454.
Score: 0.004
-
Role of age and comorbidities in mortality of patients with infective endocarditis. Eur J Intern Med. 2019 Jun; 64:63-71.
Score: 0.003
-
High Irisin levels in nondiabetic HIV-infected males are associated with insulin resistance, nonalcoholic fatty liver disease, and subclinical atherosclerosis. Clin Endocrinol (Oxf). 2018 10; 89(4):414-423.
Score: 0.003
-
Is Visceral Leishmaniasis Different in Immunocompromised Patients Without Human Immunodeficiency Virus? A Comparative, Multicenter Retrospective Cohort Analysis. Am J Trop Med Hyg. 2017 Oct; 97(4):1127-1133.
Score: 0.003
-
Subclinical atherosclerosis in low Framingham risk HIV patients. Eur J Clin Invest. 2017 Aug; 47(8):591-599.
Score: 0.003
-
Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial. Lancet Respir Med. 2017 02; 5(2):135-146.
Score: 0.003